Details For Selected Brain Tumor Treatment
Sponsored By
Buy Wine - fight brain tumors!
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.
Phase: Not Specified
Treatment ID#: 1762        
Age Group: Adults Only
Min Karnofsky Score: 70: Cares for self, unable to perform normal activity or to do active work
Conditions: Prior Surgery is Not Allowed
Prior Radiation is Not Allowed
Prior Chemotherapy is Not Allowed
Last Updated: 08/18/2007
Tumor Types: Glioblastoma Multiforme
Oligodendroglioma High Grade
Comments: The main purpose of this study is to assess the effectiveness of a two-week pre-surgery treatment with low-dose Temozolomide in patients with brain tumors suspected to be gliomas.
Treatment Type: Chemotherapy
Contact: Rolando Del Meastro MD, PhD
Montreal Neurological Institute – McGill University


Montreal, H3A 2B4 Canada
Phone: (514) 398-5791
Fax:
E-mail: rolando.delmaestro@mcgill.ca
Website: neurology.mcgill.ca/delmaestro_r.html
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment


Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites